XIIlab (189330)

KOSDAQ · 15,090 KRW · As of Aug 26, 2026 close

1Y Close · As of Aug 26, 2026

5,00010,00015,000 H 18,180L 3,475 25.0826.0526.08
Mkt Cap
141.6B
Rev (2025)
10.3B
Op Inc (2025)
-3.2B
Net Inc (2025)
-3.1B
PBR
5.63
52W
3K~18K

XIIlab operates in the Publishing sector.

Legal name: XIIlab Co., Ltd

In fiscal year 2025, XIIlab (189330) reported revenue of 10.3 billion KRW, up 13.0% from 9.1 billion KRW a year earlier.

Operating profit was -3.2 billion KRW and net income was -3.1 billion KRW in the same year.

As of the Aug 26, 2026 close, the market capitalization was 141.6 billion KRW, with a P/B of 5.63.

These figures can be verified in the DART filing (receipt no. 20260319000587).

Financials

YearRevOp IncNet Inc
202510.3B-3.2B-3.1B
20249.1B-5.3B-5.2B
20233.7B-6.9B-6.5B

Full financials →

Checks

2 applicable out of 8 items

Check details →

Recent Filings

Sales/Supply Contract

Sales/Supply Contract

Corporate Briefing (IR)

All filings →

Checks

2 of 8 checked items currently applicable.

Market Cap & Price: Market cap is above the delisting threshold.

Administrative Designation: 1 administrative designation criteria met. [source]

Audit Opinion: Audit opinion: Unqualified (clean).

Convertible Bonds: No convertible bonds outstanding.

Capital Increase: No capital-increase filings in the last 180 days.

Treasury Stock: No treasury stock filings.

Embezzlement & Litigation: No embezzlement or litigation filings in the last 180 days.

Major Shareholder Change: No major shareholder changes in the last 180 days.

Market Action: 2 market action(s) (trading halt, delisting, etc.) recorded. [source]
These checks are mechanical tests of disclosed figures and do not constitute investment advice or recommendations.

Recent Filings

DateFiling
2026-08-26Sales/Supply Contract
2026-08-20Sales/Supply Contract
2026-08-13Corporate Briefing (IR)
2026-08-13Semi-Annual Report (2026.06)
2026-08-04Trading Halt (Sales/Supply Contract)